In a major breakthrough, researchers have found that just breathing in extra oxygen could spurt the growth of tumour-fighting cells, thereby improving cancer treatment.
Supplemental oxygenation could improve cancer immunotherapy and shrink tumours by unleashing anti-tumour T lymphocytes and natural killer cells, the findings showed.
"Breathing supplemental oxygen opens up the gates of the tumour fortress and wakes up 'sleepy' anti-tumour cells, enabling these soldiers to enter the fortress and destroy it," explained Michail Sitkovsky, immunophysiology expert at the Northeastern University in the US.
However, he added, "if anti-tumour immune cells are not present, oxygen will have no impact."
"This discovery shifts the paradigm of decades-long drug development, a process with a low success rate," Sitkovsky noted.
The findings build upon Sitkovsky's previous research and represent the culmination of his life's work.
In the early 2000s, Sitkovsky made an important discovery in immunology, which has come to inform his research in cancer biology.
He found that a receptor on the surface of immune cells -- the A2A adenosine receptor -- is responsible for preventing T cells from invading tumours and for "putting to sleep" those killer cells that do manage to enter into the tumours.
His latest work carried out in mice showed that extra oxygen changed the tumour's environment so that immune cells could get inside and do their jobs.
"The anti-tumour effects of supplemental oxygen can be further improved by the natural antagonist of the A2A adenosine receptor, which happens to be the caffeine in your coffee," Sitkovsky said.
The study appeared in the journal Science Translational Medicine.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
